期刊文献+

重视Tau蛋白病理相关帕金森综合征的诊断 被引量:3

下载PDF
导出
摘要 随着分子病理的飞速发展,帕金森叠加综合征中,进行性核上性麻痹(PSP)和皮质基底节变性(CBD)的共同病理特征是微管相关蛋白Tau的异常积聚,因此被统一到Tau蛋白病理相关帕金森综合征类别中。
作者 徐俊 贾建军
出处 《中华老年心脑血管病杂志》 CAS 2016年第2期113-115,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
基金 国家自然科学基金(81271211 81471215) 江苏省科技厅社会发展重点项目(BE2015665)
  • 相关文献

参考文献13

  • 1Bluett B,Litvan I.Pathophysiology,genetics,clinical features,diagnosis and therapeutic trials in progressive supranuclear palsy.Expert Opini Orphan Drugs,2015,3:253-265.
  • 2Respondek G,Roeber S,Kretzschmar H,et al.Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy.Mov Disord,2013,28:504-509.
  • 3Oba H,Yagishita A,Terada H,et al.New and reliable MRI diagnosis for progressive supranuclear palsy.Neurology,2005,64:2050-2055.
  • 4Morelli M,Arabia G,Novellino F,et al.MRI measurements predict PSP in unclassifiahle parkinsonisms:a cohort study.Neurology,2011,77:1042-1047.
  • 5朱银伟,孙永安,陈俊,肖朝勇,时建铨,张楚楚,江炜炜,张颖冬,徐俊.磁共振帕金森综合征指数在进行性核上性麻痹预后中的价值[J].中华老年心脑血管病杂志,2013,15(3):273-276. 被引量:7
  • 6Massey LA,Jger HR,Paviour DC,et al.The midbrain to pons ratio:a simple and specific MRI sign of progressive supranuclear palsy.Neurology,2013,80:1856-1861.
  • 7Fatterpekar GM,Dietrich A,Pantano P,et al.Cerebral Peduncle Angle:An Objective Criterion for Assessing Progressive Supranuclear Palsy Richardson Syndrome.AJR Am J Roentgenol,2015,205:386-391.
  • 8Golbe L.The tau of PSP:a long road to treatment.Mov Disord,2014,29:431-434.
  • 9Josephs KA.Key emerging issues in progressive supranuclear palsy and corticobasal degeneration.J Neurol,2015,262:783-788.
  • 10Armstrong MJ,Litvan I,Lang AE,et al.Criteria for the diagnosis of corticobasal degeneration.Neurology,2013,80:496-503.

二级参考文献14

  • 1Osaki Y,Ben Shlomo Y,Lees AJ,et al. The accuracy of clini cal diagnosis of progressive supranuelear palsy. Movement Disorders, 2004,19 : 181- 189.
  • 2Williams DR,de Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven pro gressive supranuclear palsy: Richardson's syndrome and PSP- parkinsonism. Brain,2005,128 : 1247 -1258.
  • 3Quattrone A, Nicoletti G, Messina D, et al. MR imaging index for differentiation of progressive supranuclear palsy from Par kinson disease and the Parkinson variant of multiple system atrophy. Radiology,2008,246:214- 221.
  • 4Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele Rich- ardson-Olszewski syndrome) :report of the NIND-SPSP in ternational workshop. Neurology, 1996,47 : 1 -9.
  • 5Nicoletti G, Fera F, Condino F, et al. MR imaging of middle cerebellar peduncle width: differentiation of multiple system atrophy from Parkinson disease. Radiology, 2006,239 : 825 -830.
  • 6Williams D, Lees A. Progressive supranuelear palsy: clinico pathological concepts and diagnostic challenges. Lancet Neu rol, 2009,8 : 270-279.
  • 7Dickson DW,Ahmed Z,Algom AA,et al. Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol, 2010,23 : 394-400.
  • 8Williams DR,Lee W. Clinical features and criteria for the di agnosis of progressive supranuclear palsy. Neurodegener Dis Manag,2012,2: 125 -133.
  • 9Pastor P. Familial neurodegeneration in progressive supranu clear palsy. More frequent than expected? Neurology, 2009, 73 : 86-87.
  • 10Morelli M, Arabia G, Novellino F, et al. MRI measurements predict PSP in unclassifiable Parkinsonisms: a cohort study. Neurology, 2011,77 : 1042-1047.

共引文献6

同被引文献23

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部